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bsessive-compulsive disorder (OCD) is a
prevalent psychiatric disorder that is characterized by
disabling obsessions (intrusive unwanted thoughts
and/or images) and/or compulsions (ritualized repetitive
behaviors).
1 OCD was originally thought to be rare, but
a number of studies have reported a lifetime prevalence
that ranges between approximately 1% to 3% world-
wide.
2-3 Thus, it is one of the more common and serious
mental conditions.
4
Twin and family studies provide convincing evidence for
the importance of genetic factors for the expression of
OCD. The author has previously reviewed these data.
5
In this paper, the historic evidence is again summarized
and updated with recent results. Thus, sections of this
manuscript will be similar to those previously published
reviews. Supporting results from twin and family aggre-
gation studies, functional neuroimaging, pharmacologi-
cal, and molecular genetic studies provide compelling
data that suggest that biochemical/biological factors are
important for the manifestation of OCD. 
Twin studies
Twin studies are useful in determining whether genetic
factors are important in the etiology of complex disorders.
The difference in concordance rates between monozy-
gotic and dizygotic twins can be used to estimate the per-
centage of the phenotypic variance observed for a specific
trait that can be accounted for by genetic factors. 
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Obsessive-compulsive disorder (OCD) is a serious psychi-
atric disorder that affects approximately 2% of the pop-
ulations of children and adults. Family aggregation stud-
ies have demonstrated that OCD is familial, and results
from twin studies demonstrate that the familiality is due
in part to genetic factors. Only three genome-wide link-
age studies have been completed to date, with sugges-
tive but not definitive results. In addition, over 80 can-
didate gene studies have been published. Most of these
studies have focused on genes in the serotonergic and
dopaminergic pathways. Unfortunately, none have
achieved genome-wide significance, and, with the excep-
tion of the glutamate transporter gene, none have been
replicated. Future research will require the collaboration
of multidisciplinary teams of investigators to (i) achieve
sufficiently large samples of individuals with OCD; (ii)
apply the state-of-the-art laboratory techniques; and (iii)
perform the bioinformatic analyses essential to the iden-
tification of risk loci.
© 2010, LLS SAS Dialogues Clin Neurosci. 2010;12:149-163.
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Results from the early studies should be interpreted with
caution, given the limitations of those studies: most are
case reports, others have small sample sizes, still others
used different criteria to diagnose individuals, and in
most cases the investigator evaluating the cotwin was
not blind to the diagnosis of the index twin.
In the most comprehensive review to date, van
Grootheest et al
6 summarized all published twin studies
from 1929 through 2005 (Table I). Of note is that five of
the six twin studies with adequate sample sizes
32-36 (~100
twin pairs or more) attempted to estimate the heritability
of obsessive-compulsive (OC) symptoms, not OCD. Only
two studies
29-30 were able to estimate the heritability of
OCD as determined by DSM diagnostic criteria.
There have been only two additional twin study OCD
published since 2005.
29-30The first study
29 included 854 6-
year-old twins who had been identified in a community
sample and subsequently diagnosed using DSM-IV cri-
teria with information obtained in a maternal-informant
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Study type No of twin pairs MZ concordance DZ concordance
Case studies
Lange
7 3 1/2 -
Le Gras
8,9 1 1/1 -
Lewis
10 3 2/3 -
Tarozzi
11 1 1/1 -
Rüdin
12 1 - 0/1
Tienari
13 11 10/11 -
Parker
14 2 0/2 -
Wooddruff & Pitts
15 1 1/1 -
Inouye
16 14 8/10 1/4
DSM-III/DSM-III-R OCD
Marks et al
17 1 1/1 -
Tarsh
18 1 - 1/1
Hoaken & Schurr
19 1 0/1 -
McGuffin & Mawson
20 2 2/2 -
Carey & Gottesman
21 30 13/15 7/15
Torgerson
22 12 0/3 0/9
McKeon et al
23 1 0/1 -
Mahgroub et al
24 1 1/1 -
Kim et al
25 1 1/1 -
Andrews et al
26 48 0/18 0/30
Lewis et al
27 3 3/3 -
Cryan et al
28 1 1/1 -
DSM-IV MZ tetrachoric r DZ tetrachoric r
Bolton et al
29 854 0.57 (0.24-0.80) 0.22 (-0.02-0.43)
Tambs et al
30
OC behaviors h
2
Young et al
31 32 0
Torgerson
32 99 0.18 (men); 0.23(women)
Clifford et al
33 419 0.44(traits); 0.47(symptoms)
Jonnal et al
34 527 0.33(obsessions); 0.26(compulsions)
Eley et al
35 4 564 0.65 (OC behavior)
Hudziak et al
36 4 246 0.45 – 0.61
Table I. Twin studies of OCD.
Adapted from ref 5: Pauls DL. The genetics of obsessive compulsive disorder: a review of the evidence. Am J Med Genetics C: Sem Med Genet. 2008;148:133-
139. Copyright © Wiley-Liss 2008
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size to adequately evaluate the influence of genetic fac-
tors on OCD, not just OC symptoms in the general pop-
ulation of twins. The Bolton et al
29 findings are consistent
with the majority of studies with sufficient sample sizes
(Table I) in that the results support the hypothesis that
genetic factors play a significant role in the etiology of
OC behaviors as well as OCD. 
In addition, these investigators also examined the rela-
tion between OCD and two commonly occurring comor-
bid disorders: tic disorder and anxiety disorders. Their
findings support the hypothesis that there are shared eti-
ologic factors for OCD and tics, as well as OCD and
other anxiety disorders, and are consistent with the
hypothesis that there may be different subtypes of OCD
that may have different underlying risk factors.
37-41 This
hypothesis will be discussed in more depth in the Family
Studies section below.
The second study, published in 2009,
30 obtained data
from 2801 young-adult Norwegian twins by means of the
Composite International Diagnostic Interview (CIDI).
This study examined the heritability of five anxiety dis-
orders (Generalized Anxiety Disorder, Panic Disorder,
Phobias, Obsessive-Compulsive Disorder, and Post-
Traumatic Stress Disorder.) Valid anxiety data were
available for 1385 twin pairs; however, there were only
57 pairs where one twin had a diagnosis of OCD.
Because the prevalence of OCD was so low in this sam-
ple, the investigators included individuals who met cri-
teria or subthreshold OCD (the number of pairs where
at least one had a diagnosis of OCD or subthreshold
OCD was 165). The estimate of heritability was 29%.
However, these investigators reported that 55% of this
heritability was due to a common factor shared by all
five anxiety disorders. On the other hand, 45% appear
to be due to factors that were specific to OCD.
In summarizing the studies published prior to 2006, van
Grootheest and colleagues
6 concluded that “in children,
obsessive-compulsive (OC) symptoms are heritable, with
genetic influences in the range of 45% to 65%. In adults,
studies are suggestive for a genetic influence on OC
symptoms, ranging from 27% to 47%...” The findings
from the two most recent studies
29,30 are remarkably sim-
ilar when cotwins who met criteria for subclinical OCD
were included in the analyses. Both studies reported that
additive genetic effects accounted for 29% of the vari-
ance for OCD and subclinical OCD. In the Bolten
study,
29 familial aggregation due to combined additive
genetic and shared environmental effects accounted for
47% of the phenotypic variance. Unfortunately, these
investigators were unable to estimate the effects of addi-
tive genetic and shared environmental separately.
29
Family studies
Numerous family studies on OCD and obsessional neu-
rosis have been published since 1930 (Table II). Results
from the majority of these studies demonstrate that at
least some forms of OCD are familial, and the findings
from twin studies summarized above provide evidence
that this familiality is due in part to genetic factors.
However, it is also evident that environmental/cultural
factors influence OC behaviors and are also transmitted
within families.
29 These nongenetic factors unquestion-
ably influence the manifestation of OC behaviors as evi-
denced from twin studies that consistently demonstrate
that the concordance rate of MZ twins for OC behaviors
and OCD is always less than 1.0. Understanding the
impact of these environmental/cultural factors will be
critical to the eventual elucidation of the risk factors
important for the manifestation of complex disorders
such as OCD. However, while it is clear that genes alone
will not explain all of the observed inheritance of OCD,
demonstrating familiality is an important step for the
eventual determination of the importance of genetic risk
factors.
Family history studies
Studies in which all diagnostic data about family mem-
bers are obtained from one or two informants are
referred to as family history studies. Prior to 1987, all
studies of the familiality of OC illness and/or OC features
relied on family history data. It has been shown that, in
general, family history data yields underestimates of the
true rates of illness within families.
42-43 Hence, it is signif-
icant that these early family history studies reported find-
ings suggesting that OC illness and/or OC features were
familial (Table II). An important shortcoming of all of
these early studies was that no control samples were
obtained to estimate the rate of OC illness or OC fea-
tures in the general population. Thus, all of these data
need to be interpreted with that caveat in mind.
In only one study,
49 results were reported that were not
consistent with OC illness and/or features being famil-
ial. In this study, a relative was considered affected only
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criterion, no significant increase of OC illness among
first-degree relatives of 144 obsessional neurotics was
observed, although an increased rate of psychiatric ill-
ness among these relatives was reported. Unfortunately,
no information about OC symptomatology among rela-
tives who were not hospitalized was provided. 
Direct interview family studies
Subsequent to 1986, all family studies collected direct
interview from at least some of the relatives in the fam-
ily. With the exception of one study,
52 all available rela-
tives were directly interviewed. In the study by McKeon
and Murray
52 all family members of adult probands with
OCD were given the Leyton Obsessional Inventory
(LOI), and only those relatives who scored high on the
LOI were directly interviewed. Only one of the inter-
viewed relatives met criteria for OC neurosis, suggesting
that the disorder is not familial. 
It is possible that some relatives with OCD may not
have been identified with this ascertainment scheme.
Low scores on the LOI can be observed in individuals
having only a few obsessions and/or compulsions which
consume significant time and cause considerable distress
and result in a diagnosis of OCD. Thus, it is possible that
some of the noninterviewed relatives could have scored
low on the LOI yet still met criteria for a diagnosis of
OCD. In should be noted, however, that these investiga-
tors did observe an increased rate of mental illness over-
all among the relatives of these OCD probands.
The remaining 15 family studies of OCD interviewed all
Translational research
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Family history studies Obsessive-compulsive illness Obsessive-compulsive features Controls
Luxenburger
44 0.08 0.08 ---
Lewis
45 --- 0.327 ---
Brown
46 0.073 --- ---
Rüdin
47 0.040 0.070 ---
Kringlen
48 0.198 ---
Rosenburg
49 0.004 --- ---
Insel et al
50 0 0.150 ---
Rasmussen & Tsuang
51 0.045 0.114 ---
Adult family studies OCD Subclinical OCD OCD Subclinical OCD
Mckeon & Murray
52 0.007 --- 0.007
Bellodi et al
53 0.034 --- --- ---
Black et al
54 0.025 0.156 0.023 0.029
Nicolini et al
55 0.049 --- --- ---
Pauls et al
38 0.103 0.079 0.019 0.020
Nestadt et al
56 0.117 0.046 0.027 0.030
Albert et al
57 0.035 --- --- ---
Fyer et al
58 0.062 0.084 0 0
Lipsitz et al
59* 0.026 0.057 0.013 0.013
Grabe et al
60** 0.064 0.055 0.012 0.030
Child family studies OCD Subclinical OCD OCD Subclinical OCD
Lenane et al
61 0.170 --- --- ---
Riddle et al
62 0.095 --- --- ---
Leonard et al
63 0.130 --- --- ---
Reddy et al
64 0.050 --- 0 ---
Chabane et al
65 0.170 --- --- ---
Hanna et al
40 0.225 --- 0.026 ---
Rosario-Campos et al
41 0.227 0.065 0.009 0.015
Table II. Family studies of OCD. The rates shown refer to the frequency of these conditions among first-degree relatives.  
Adapted from ref 5: Pauls DL. The genetics of obsessive compulsive disorder: a review of the evidence. Am J Med Genetics C: Sem Med Genet. 2008;148:133-
139. Copyright © Wiley-Liss 2008
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atric interviews.
38,40-41,53-65 In some of these studies, addi-
tional information was obtained from all interviewed rel-
atives about the presence of OCD in all of their
first-degree relatives; even those relatives that had been
directly interviewed. Thus, both direct interview data and
family history data were available for all interviewed
individuals in those family studies. 
While there were some inconsistent results, most of
these studies provided data that are consistent with the
hypothesis that some forms of OCD are familial (Table
II). In seven studies ascertainment was through children
and/or adolescents with OCD (Table II). In the remain-
ing eight studies, ascertainment was through adults with
OCD (Table II).
Studies of families ascertained through child/adolescent
probands
In all of the studies in which all available relatives of
children and/or adolescents with OCD were inter-
viewed,
40-41,61-65 the rates of OCD and subclinical OCD
were significantly higher than the population prevalence
and/or the rate obtained in controls assessed in the same
way. While the frequency of OCD and subclinical OCD
differed within families across studies, the overall con-
clusion was the same: OCD and subclinical OCD are
familial. Furthermore, the recurrence risks within these
families were considerably higher than the rates
observed in families ascertained through adults (see
below). While the rate of OCD among relatives of adults
with OCD was approximately two times that among
controls, the rate of OCD among relatives of children
and adolescents with OCD was increased approximately
10-fold in those studies where comparison with controls
was possible.
Studies of families ascertained through adult probands
The results from studies of families ascertained through
adults with OCD in which all available relatives were
interviewed were not as consistent as those family stud-
ies of child and/or adolescent probands summarized
above. As noted above, the study by McKeon and
Murray
52 did not observe an increased rate of OCD
among relatives of adult OCD probands. In addition,
Black et al
54 reported results of a study examining 120
first-degree relatives of 32 adult OCD probands and 129
relatives of 33 psychiatrically age-matched normal con-
trols. This was the first controlled study of OCD in which
all relatives were assessed using structured interviews
and all interviewers were blind to the diagnostic status
of the proband. DSM-III criteria were used to assign all
diagnoses from the direct interview data. While family
history data had been obtained from all interviewed rel-
atives about other first-degree relatives, none of those
data were included in the diagnostic process. These
investigators reported an age-corrected rate of DSM-III
OCD of 2.5% among relatives of probands compared
with 2.3% in controls. These data suggest that OCD is
not familial. However, when a more broadly defined
OCD was used in the analyses the rate among parents
of OCD probands was 15.6%. In contrast to the rate
among the parents of control individuals was 2.9%. It is
noteworthy that these investigators also reported an
increased rate of non-OCD anxiety among the relatives.
It is possible that, since in this study only direct interview
data were used in the diagnostic process, the estimated
recurrence risks could have been biased. Lipsitz et al
59
examined whether using informant information influ-
enced the recurrence risk estimates. In most family stud-
ies of OCD diagnoses are based on all direct interview
and family history data collected from informants in the
family. When only data from the direct interviews were
used to assign diagnoses, there was not a significant
increase in the occurrence of OCD among the relatives.
The rate of OCD and subclinical OCD for interviewed
relatives when no informant information was used in the
diagnostic process was 5.4% compared with 1.7% among
controls (P=0.17). On the other hand, the rate of OCD
and subclinical OCD among interviewed relatives when
additional informant data were used was 8.9% compared
with only 1.7% among controls (P=0.02). These investi-
gators concluded that “evidence of familial transmission
of OCD was found only when diagnoses were made
using information from the proband about the relative.”
As an explanation for these differences, these authors
suggest that since individuals with OCD can be quite
secretive about their symptoms, it is possible that upon
direct interview, they might deny OC symptomatology.
This could be particularly important in the case when the
individual being interviewed has never sought treatment
for their OC symptoms. On the other hand, it is also pos-
sible that an affected relative who has sought treatment
or proband may “over-report” symptoms in their rela-
tives. In the Lipsitz et al
59 study, family history informa-
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whom had sought treatment, so it is possible that there
was “projection” of their own behaviors onto their rela-
tives, resulting in over-reporting of affected status.
However, in other studies where family history data were
collected from all interviewed relatives,
3,8,56 information
was collected from both affected and unaffected relatives,
and therefore it is less likely that there would be over-
reporting of OC symptomatology, since unaffected rela-
tives would not be “projecting” their own behavior onto
their relatives. Of note is that in the study of Lipsitz et
al,
59 an increased rate of other non-OCD anxiety disor-
ders was observed. Finally, Black and colleagues did
report that a number of family members were reported
to have OC symptomatology by their relatives. Thus, it is
possible that, if all available information had been used
to assign diagnoses, the recurrence risk for OCD among
first-degree relatives could have been higher than
reported.
All of the remaining studies of families ascertained
through adult individuals with OCD provide evidence
that OCD is a familial disorder.
38,53,55-58,60 In these studies,
the rate of OCD among relatives of affected individuals
was significantly higher than either the estimated popu-
lation prevalence or rate among controls. In the most
recently published study,
60 the investigators ascertained
affected individuals from both a population sample and
a clinic sample. They observed a significant increase in
both relatives of individuals who were ascertained
through an OCD clinic and individuals who were iden-
tified through a population study of OCD. The study by
Grabe et al was the first controlled study of OCD in
Europe, and confirmed the results of earlier studies com-
pleted in the US
38,56,58 with families ascertained through
treatment facilities. The finding that relatives of both
clinic patients and individuals identified in a population
based study is important. As the authors nicely summa-
rize, “the finding of a comparable familial aggregation
of definite OCD and a higher familial aggregation of
subclinical OCD in relatives of never treated persons
with OCD from the community strongly supports the
impact of familial-genetic factors in OCD.” 
Associated conditions
As noted in the discussion of twin studies, a number of
investigators have examined family data to test the
hypothesis that other disorders may be significantly
increased among relatives of OCD probands. Additional
analyses of the Hopkins OCD Family Study
56 were
reported.
66-67 Bienvenu et al
66 explored OC-spectrum dis-
orders among proband relatives and found significantly
higher rates of BDD (OR=5.4), somatoform disorders
(OR 3.9), grooming disorders (OR=1.8), and all spectrum
disorders combined (OR=2.7). Similarly, Grados et al
67
explored OCD comorbidity and found an increased preva-
lence of tic disorders among proband relatives versus con-
trol relatives. There was also an association between ear-
lier age of OCD onset and tic comorbidity. These findings
are consistent with those reported earlier.
29,38,,41These find-
ings suggest that there may be at least three different types
of OCD: (i) one that is inherited and related to TS; (ii) one
that is inherited and not related to TS but possibly related
to anxiety; and (iii) one that is not familial.
In sum, these studies of OCD probands and their rela-
tives cumulatively provide strong evidence that some but
possibly not all forms of OCD are familial. This was con-
firmed in a meta-analysis of five family studies of OCD
probands published prior to 2001 involving 1209 first-
degree relatives
68 in which a significantly increased risk
of OCD among relatives of probands was observed
(Mantel-Haenszel summary OR=4.0 (95% CI=2.2-7.1)).
The unadjusted aggregate risk for relatives of OCD
probands was 8.2%, compared with 2.0% for relatives of
relatives. Although these family study findings are con-
sistent with a genetic etiology of OCD, by themselves
they only demonstrate that OCD is familial; not that
genetic factors are necessary for the manifestation of the
illness. However, taken together with the evidence from
twin studies, there is compelling evidence that genetic
factors play an important role in the manifestation of
some forms of OCD.
Segregation analyses
Given that the majority of studies demonstrated that
OCD is familial, and twin studies suggest that this famil-
iality is in part due to genetic factors, the next step has
been to examine whether the mode of transmission in
these families can be explained by specific genetic mod-
els. Complex segregation analyses allow an examination
of specific genetic models by estimating the “goodness-
of-fit” of the pattern of transmission specified by an
hypothesized genetic model to that of the observed pat-
terns of transmission within families. While complex seg-
regation analyses do not prove the existence of genes
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can reveal patterns of transmission within families that
may be helpful in future molecular genetic studies.
To date, four complex segregation analyses of OCD
transmission in families ascertained through OCD
probands have been reported.
69-72All studies provided
evidence that the transmission of OCD within families
is consistent with genetic transmission. However, the
genetic model that best explained the transmission
within families differed from study to study. Given the
variability of recurrence risks observed in the family
studies and the clinical heterogeneity that is evident in
OCD, this result is not surprising. Nevertheless, it is note-
worthy that the conclusions of the authors in all of these
reports were that there are some genes of major effect
important for the manifestation of OCD. Given the vari-
ability in the estimates of recurrence risks in the
reported studies, it is quite likely that OCD is an oli-
gogenic disorder (ie, a number of genes are important
for the expression of the disorder). 
In addition to advances in understanding regarding
familiality and genetic mechanisms that are likely to be
involved in OCD, there have also been dramatic gains in
our understanding of the phenotype of OCD. Perhaps
most important for genetic research are new ways to
assess the phenotype dimensionally, moving beyond tra-
ditional categorical diagnostic classifications. Over the
last decade, results from a number of independent stud-
ies have demonstrated that there are different clusters
of symptoms that comprise the OCD phenotype
73-77 and
that they appear to be heritable.
73,76 It follows then that
there may be several genes that could influence the dif-
ferent components of OCD. 
Candidate gene studies
Given current theoretical understanding of mechanisms
that may be implicated in the emergence and mainte-
nance of OCD symptoms and the treatment of the dis-
order, a number of investigators have pursued genetic
studies of specific genes that are known to be involved
in systems implicated in the pathogenesis of OCD. In
particular, because of the efficacy of serotonin reuptake
in treating OCD,
78-79 a number of genes important in the
serotonergic system have been examined. In addition,
genes in the dopaminergic, glutamatergic, and opioid
systems have also been studied to determine if they also
contribute to the risk of OCD.
80
Over 80 candidate gene studies have been published
over the last decade (Table III). As noted above, asso-
ciation studies have examined candidate genes that func-
tion within the serotonergic and dopaminergic systems
and more recently the glutamatergic system based on
knowledge of the pathophysiology and pharmacology of
OCD. However, with the exception of the glutamate
transporter gene SLCL1A1,
81-84 none have been consis-
tently replicated. While some of the more recent pub-
lished studies have larger sample sizes, all have inade-
quate sample sizes to achieve genome-wide significance
(ie, 5x10
-8). Some recent studies have moved beyond sim-
ply documenting that individuals with OCD are more
likely to have a specific allele or candidate gene that
other nonaffected individuals (ie, association studies)
and have begun to explore the function of some of the
genes being studied. Preliminary results suggest that may
be a promising approach.
85 However, none of these stud-
ies have yet been replicated, so it is too early to reach
any definite conclusions.
Given the complexity of the OCD phenotype, it is highly
unlikely that any of the candidate genes examined to
date will be significant, unique risk factors for OCD.
Thus, although they may truly be associated with the
onset, severity, or persistence of OCD symptoms, they
are unlikely to cause OCD without the presence of other
risk genes. On the other hand, since most current effec-
tive pharmacologic agents target the serotonergic and
dopaminergic systems, it is possible that some of the
genes in those systems could play a role in treatment
response. Knowing which genes impact treatment
response would be a major advance in the treatment of
OCD and is consistent with the primary goal of the
emerging field of pharmacogenetics. However, it would
not necessarily demonstrate that those genes are
involved in the etiology of OCD. Genes involved in
response to treatment may not be involved in the etiol-
ogy of a disorder.
Genetic linkage studies
Only three genome-wide linkage studies of OCD have
been completed to date.
135-137 No study yielded genome-
wide significance; however all studies suggested regions
of interest for future research. Hanna et al
136 completed
a genome scan on seven families which included 66 indi-
viduals. All families had been identified through child-
hood OCD probands. All but one of the relatives were
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Candidate gene Investigator Study design Sample size Significance Associated allele
Serotonin transporter Cases Controls Families
McDougle et al
86 FB --- --- 35 P<0.03 L allele
Bengel et al
87 CC 75 397 --- P=0.023 LL genotype
Frisch et al
88 CC 75 172 --- ns ---
Kinnear et al
89 CC 54 82 --- ns ---
Denys et al
90 CC 156 134 --- ns ---
Dickel et al
91 FB --- --- 54 ns ---
Saiz et al
92 CC 99 420 -- ns ---
Wendland et al93 CC 347 749 --- ns ---
Wendland et al
84 CC 295 657 -- P<0.018 3 marker haplotype
Serotonin transporter promoter
Kinnear et al
94 CC 129 479 --- ns ---
Camarena et al
95 CC/FB 115 136 43 ns ---
Cavallini et al
96 CC 180 112 --- ns ---
Walitza et al
97 FB --- --- 63 ns ---
Meira-Lima et al
98 CC 79 202 --- ns ---
Chabane et al
99 CC/FB 106 171 86 ns ---
Serotonin receptor 2A
Nicolini et al
100 CC 67 54 --- ns ---
Enoch et al
101 CC 62 144 --- P<0.05 A allele
Enoch et al
102 CC 101 138 --- P=0.015 A allele
Frisch et al
88 CC 75 172 --- ns ---
Walitza et al
103 CC 55 223 --- ns ---
Hemmings et al
104 CC 71 129 --- ns ---
Tot et al
105 CC ?? ?? --- ns ---
Hemmings et al
106 CC 58 83 --- ns ---
Meira-Lima et al
98 CC 79 202 --- P<0.00007 C - Allele
Denys et al
90 CC 156 134 --- ns ---
Dickel et al
91 FB --- --- 54 ns ---
Saiz et a
92 CC 99 420 --- P=0.02 ---
Serotonin receptor 2C
Cavallini et al
107 CC 109 107 --- ns ---
Frisch et al
88 CC 75 172 --- ns ---
Meira-Lima et al
98 CC 79 202 --- ns ---
Cavallini et al
107 CC 109 107 --- ns ---
Frisch et al
88 CC 75 172 --- ns ---
Meira-Lima et al
98 CC 79 202 --- ns ---
Serotonin receptor 1B (1Dβ)
Mundo et al
108 FB --- --- 32 P<0.006 G allele
Mundo et al
109 FB --- --- 121 P=0.023 G allele
DiBella et al
110 FB --- --- 48 ns ---
Hemmings et al
104 CC 77 129 --- ns ---
Camarena et al
111 FB --- --- 47 ns ---
Walitza et al
97 FB --- --- 63 ns ---
Table III. Candidate gene studies of OCD. *Association with the hoarding phenotype
Adapted from ref 134 (and updated through 11/2009): Hanna GL, Veenstra-VanderWeele J, Cox NJ, et al. Genome-wide linkage analysis of families with obses-
sive-compulsive disorder ascertained through pediatric probands. Am J Med Genet. 2002;114:541-552. Copyright © Wiley-Liss 2002
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Candidate gene Investigator Study design Sample size Significance Associated allele
Cases Controls Families
Denys et al
90 CC 156 134 --- ns ---
Dickel et al
91 FB --- --- 54 ns ---
Tryptophan hydroxylase
Frisch et al
88 CC 75 172 --- ns ---
Walitza et al
97 FB --- --- 63 ns ---
Mössner et al
112 FB --- --- 71 P=0.035 G-C Haplotype
Dopamine receptor 4
Cruz et al
113 CC 12 49 --- P= 0.018
Billet et al
114 CC 118 118 --- P= 0.021
Frisch et al
88 CC 75 172 --- P=0.04 7 allele less frequent
Millet et al
115 CC/FB 49 63 34 P=0.03 2 allele protective
Hemmings et al
104 CC 71 129 --- ns ---
Hemmings et al
106 CC 95 85 --- P=0.013 early vs late onset
Dopamine receptor 2
Nicolini et al
100 CC 67 54 --- ns ---
Billet et al
114 CC 110 110 --- P=0.014 CC genotype
Dopamine receptor 3
Catalano et al
116 CC 97 97 --- ns ---
Nicolini et al
100 CC 67 54 --- ns ---
Billet et al
114 CC 103 103 --- ns ---
Dopamine transporter
Billet et al
114 CC 103 103 --- ns ---
Frisch et al
88 CC 75 172 --- ns ---
Hemmings et al
104 CC 71 129 --- ns ---
Dopamine receptor 2
Nicolini et al
100 CC 67 54 --- ns ---
Billet et al
114 CC 110 110 --- P=0.014 CC genotype
Dopamine receptor 3
Catalano et al
116 CC 97 97 --- ns ---
Nicolini et al
100 CC 67 54 --- ns ---
Billet et al
114 CC 103 103 --- ns ---
Dopamine transporter
Billet et al
114 CC 103 103 --- ns ---
Frisch et al
88 CC 75 172 --- ns ---
Hemmings et al
104 CC 71 129 --- ns ---
Monamine oxidase A
Karayiorgou et al
117 FB --- --- 110 P=0.019 (males) G allele 
Camarena et al
95 CC/FB 122 124 51 CC: P=0.024 T allele
FB: P=0.022
Hemmings et al
104 CC 71 129 --- ns ---
Catechol O-methyl transferase
Karayiorgou et al
118 CC 73 148 --- P=0.0002  L allele in males 
Karayiorgou et al
117 FB --- --- 110 P=0.0079 L allele
Schindler et al
119 FB --- --- 67 P=0.006 L allele
Table III. Continued
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and 32 received diagnosis of lifetime OCD.
Three hundred forty-nine microsatellite markers were
genotyped on these families. Twenty-four additional
markers included in the fine-mapping subsequent to the
initial genome scan. In the initial analyses a LOD score
of 2.25 for marker D9S288 on chromosome 9p was
observed. However, after finemapping the LOD score
dropped to 1.97. In general, LOD scores above 3.6 are
considered to be genome-wide significant.
In an attempt to replicate these findings, Willour et al
138
genotyped microsatellite markers on all available rela-
tives in 50 pedigrees which had been ascertained
through persons with OCD. The largest LOD scores
observed in this study were for markers D9S1792
(HLOD=2.26) D9S1813 (NPL=2.52, P=0.006). D9S1813
and D9S1792 are within 350 kb of marker D9S288, the
marker yielding the largest LOD score reported by
Hanna et al. 
The second genome-wide linkage study included a total
of 219 families. Both affected sib-pair and multigenera-
tional families were genotyped.
136 Suggestive evidence
was observed for susceptibility loci on chromosomes 3q,
7p, 1q, 15q, and 6q. The strongest linkage evidence was
obtained for markers on chromosome 3q27-28 when
both definite and probable cases of OCD were consid-
ered affected. The maximum overall Kong and Cox
LODall score (2.67) occurred with markers D3S1262
Translational research
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Candidate gene Investigator Study design Sample size Significance Associated allele
Cases Controls Families
Niehaus et al
120 CC 54 54 --- P=0.0017 HL genotype
Alsobrook et al
121 FB --- --- 56 P=0.048 L allele in females
Ohara et al
122 CC 17 35 --- ns ---
Erdal et al
123 CC 59 114 --- ns ---
Azzam et al
124 CC 144 337 --- ns ---
Meira-Lima et al
98 CC 79 202 --- ns ---
Katerberg et al
125 CC 373 462 --- ns ---
Glutamate receptor  Arnold et al
126 FB --- --- 130 P=0.002 5072G-5988T haplotype
subtype 2B
Kainite glutamate  Delorme et al
127 CC/FB 156 156 141 CC: ns 867I allele
receptor 2 FB: P=0.03 undertransmitted
Gamma-Amino-butyric  Zai et al
128 FB --- --- 159 P=0.006 A-7265G
acid type B receptor 1
Brain-derived neurotropic factor
Hall et al
129 FB --- --- 164 P<0.020 Multiple SNPs 
Dickel et al
91 FB --- --- 54 ns ---
Wendland et al
93 CC 347 749 --- ns ---
Myelin oligo-dendrocyte
Zai et al
130 FB --- --- 160 P=0.022 MOG4 2-repeat allele
Glutamate transporter
Arnold et al
81 FB --- --- 157 P=0.006 2 marker haplotype (males)
Dickel et al
82 FB --- --- 71 P=0.030 2 marker haplotype (males)
Stewart et al
83 FB --- --- 66 P=0.0015 3 marker haplotype
Wendland et al
84 CC 325 662 --- P<0.001 3 marker haplotype
Oligo-dendrocyte lineage  Stewart et al
131 FB --- --- 66 P=0.004 5 marker haplotype 
transcription factor 2
Neurotrophin-3 receptor  Muiños-Gimeno et al
132 CC 153 324 --- P=0.005 ---
gene (NTRK3)*
Extraneuronal monoamine  Lazar et al
133 CC 84 204 ns ---
transporter, EMT (SLC22A3)
Table III. Continued
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posed by Kong and Cox estimates the degree of allele
sharing between affected individuals and provides using
a maximum likelihood approach. When there is no link-
age there should be no allele sharing greater than
expected by chance.
In a second set of analyses of 219 families, Samuels et
al
139 examined whether compulsive hoarding behavior
was linked to different markers across the genome.
These investigators reported suggestive evidence for
linkage for D14S588 (KAC(all)=2.9) on chromosome 14.
When families which included two or more hoarding rel-
atives were analyzed separately, the Kong and Cox
LODall score increased to 3.7.
In the third genome-wide linkage study,
137 121 individuals
in 26 multigenerational families were genotyped with
markers with an average spacing of 10 centimorgans
(cM). (Note: a centimorgan is defined as the distance on
a chromosome in which 1% crossing over occurs. Given
the success of the human genome project, this metric is
rarely used any more, since it is now possible to deter-
mine precisely the number of base pairs between mark-
ers.) As in the first study published by these investiga-
tors,
135 all relatives were assessed with a semistructured
psychiatric interview, and best estimate lifetime psychi-
atric diagnoses were made using data from these inter-
views and all other available sources of information. The
maximum nonparametric LOD (NLOD) score observed
was 2.43 for markers on chromosome 10p15. When data
from Hanna et al’s first genome scan were analyzed
together with the current marker data, the maximum
NLOD score in the 10p15 region was decreased to 1.79.
These investigators followed up the linkage findings with
a family-based association analysis which examined 35
single-nucleotide polymorphisms (SNPs) in this 10p15
region. Association was detected on 10p15 with three
adjacent SNPs, including the amino acid variant
rs2271275 in the 3' region of adenosine deaminase act-
ing on RNA 3 (ADAR3) (P<.05). 
All of these findings should be interpreted with caution.
The sample sizes in all three studies were quite small.
Nevertheless, given that Willour et al
138 observed sug-
gestive linkage to the same chromosome 9p region as
reported by Hanna et al is noteworthy. In addition, as
discussed above, four independent studies have reported
an association of OCD and the glutamate transporter
which is located in this region on 9p. Thus, the findings
from the two studies by Hanna and colleagues
135,137 and
the one reported by Willour et al
138 suggest that there
may be a susceptibility locus in this region of 9p.
Unfortunately, this region did not show any evidence for
linage in the study completed by Shugart et al.
136
Future work
The twin and family studies summarized in this review
demonstrate that at least some forms of OCD have a
genetic basis. However, given that none of the linkage
studies and essentially all of the candidate genes studies
provide only suggestive evidence for risk genes of mod-
erate-to-large effect, whole-genome association studies
of OCD are warranted as the next step in our under-
standing of the genetic basis of the disorder. Whole-
genome association studies are preferred over more tra-
ditional linkage studies or candidate gene studies
because they provide more power to identify risk genes
of relatively small effect. The primary difference
between genome-wide linkage studies and genome-wide
association studies (GWASs) is that with linkage the
investigator is looking for cotransmission of a specific
DNA marker within a family, while in a genome-wide
association study the investigator is looking for a pop-
ulation association between a DNA marker and disease.
Linkage studies are better suited to identifying genes
that have large effects, and GWASs are better when
attempting to identify genes that have relatively small
effects on the phenotype. These GWASs should exam-
ine both common markers as well a copy number vari-
ants and other rare genetic events. It is becoming evi-
dence that complex disorders may be “caused” by both
rare genes of major effect and a combination of common
genes of lesser effect.
Given the limited state of knowledge about the patho-
physiological pathways important for the manifestation
of OCD, it is premature at this time to restrict focus on
the association of specific candidate genes with OCD.
Instead, a GWAS with a sample of sufficient size is the
most promising approach for the identification of
genomic regions that most likely harbor OCD risk genes.
Once these regions have been identified, then more
informed candidate gene studies could be undertaken. 
Given the variability of recurrence risks and the results
from the most recent twin study, it is clear that, like other
neuropsychiatric conditions, OCD is etiologically het-
erogeneous. Given this high likelihood of etiologic het-
erogeneity, it is critical to study a sufficiently large sam-
Genetics of OCD - Pauls Dialogues in Clinical Neuroscience - Vol 12 . No. 2 . 2010
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subgroups more likely to be etiologically homogenous
can be identified from within the larger sample.
140-141 In
order to obtain these large samples, it is imperative that
investigators interested in the genetics of OCD collabo-
rate. A collaboration of this type (the International OCD
Foundation Genetics Collaborative) is currently con-
ducting a GWAS of OCD on samples contributed from
21 different research sites from around the world. ❏
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La genética del trastorno obsesivo-
compulsivo: una revisión
El trastorno obsesivo-compulsivo (TOC) es un serio
trastorno psiquiátrico que afecta aproximadamente
al 2% de la población de niños y adultos. Los estu-
dios de agregación familiar han demostrado que el
TOC es familiar y los resultados de los estudios en
gemelos demuestran que el carácter familiar se
debe en parte a factores genéticos. A la fecha se
han terminado sólo tres estudios del ligamiento de
genoma completo, con resultados sugerentes, pero
no definitivos. Además, se han publicado más de 80
estudios de genes candidatos. La mayoría de estos
estudios se han focalizado en genes de las vías sero-
toninérgica y dopaminérgica. Lamentablemente,
ninguno de ellos ha logrado una significación para
el genoma completo y, con excepción del gen del
transportador de glutamato, ninguno ha sido repli-
cado. La investigación a futuro requerirá de la cola-
boración de equipos multidisciplinarios para: 1) con-
seguir muestras suficientemente grandes de
individuos con TOC, 2) aplicar las técnicas de labo-
ratorio más actualizadas y 3) realizar los análisis
bioinformáticos esenciales para la identificación de
los loci de riesgo.   
Génétique du trouble obsessionnel 
compulsif : revue de la littérature
Le trouble obsessionnel compulsif (TOC) est un
trouble psychiatrique grave affectant environ 2 %
de la population enfant et adulte. Des études
d’agrégation familiale ont montré que le TOC est
d’origine familiale, le résultat d’études sur les
jumeaux ayant mis en évidence que le caractère
familial serait dû en partie à des facteurs géné-
tiques. Seules trois études de liaison du génome
entier sont terminées à ce jour, avec des résultats
évocateurs mais pas définitifs. De surcroît, plus de
80 études sur les gènes candidats ont été publiées.
La plupart des études se sont intéressées aux gènes
des voies sérotoninergiques et dopaminergiques.
Malheureusement, aucune n’a pu être significative
sur génome entier et, mis à part le gène transpor-
teur du glutamate, aucune n’a pu être reproduite.
La recherche ultérieure nécessitera la collaboration
d’équipes pluridisciplinaires d’investigateurs pour
1) obtenir des échantillons suffisamment importants
de sujets atteints de TOC ; 2) appliquer des tech-
niques de laboratoires optimales ; et 3) réaliser des
analyses bio-informatiques essentielles à l’identifi-
cation des loci à risque.
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